Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengkang Medical Group, formerly known as Gansu Duyiwei Pharmaceutical, is a diversified healthcare company based in China that operates across pharmaceutical manufacturing and medical services. The company is widely recognized for its Duyiwei series of traditional Chinese medicines, which are primarily used for pain relief, hemostasis, and anti-inflammatory purposes. Beyond its pharmaceutical core, Hengkang Medical has expanded significantly into the healthcare services sector, acquiring and managing a network of hospitals specializing in oncology, maternity, and general medicine. The group integrates drug research and development, manufacturing, and clinical care to provide comprehensive health solutions. Despite facing financial restructuring in recent years, it remains a significant player in the Chinese private hospital management and pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengkang Medical Group.